How RWE can support drug development during COVID-19 and beyond
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
COVID-19 has heightened the need for an expanded understanding of clinical trial populations and...
In just a few years, artificial intelligence (AI) has become a trusted tool in early drug discovery. Researchers using models like AlphaFold 3, RoseTTAFold All-Atom and others, can predict protein structures, design potential compounds and simulate d...